Meissner was previously listed in April as a consultant to the RSV vaccines work group for the CDC committee, before Kennedy ...

A new study from UCLA Health suggests COVID-19 vaccines may protect patients from severe kidney damage. The study found ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Ng reported personal fees from Bayer, Pfizer, CytomX, Jazz Pharmaceuticals, Revolution Medicines, Agenus, Johnson & Johnson, ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

Robert F. Kennedy Jr. faced questions from Congress about his own potential conflicts of interest during a confirmation ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

Efimosfermin is a long-acting engineered variant of FGF21 designed to have a prolonged half-life, the authors noted, and has ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

Pfizer Inc. (NYSE:PFE) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider of Goldman ...

Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing ...

While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their ...